Search Results 1851-1860 of 17692 for rheumatoid arthritis

  1. Physical Medicine and Rehabilitation - Doctors - Mayo Clinic

    Jeffrey S. Brault, D.O.. Physiatrist. Rochester, MN. Areas of focus: Botox injection, Hand therapy, Arthritis rehabilitation, Exercise therapy, ...

  2. Bursitis - Doctors and departments - Mayo Clinic

    ... arthritis, Shoulder arthritis, Hip tendon tear, Knee cartilage injury, Achilles tendinopathy. Show more areas of focus for Chris Ha, D.O. ...

  3. Study of Radium-223 Dichloride Versus Placebo and Hormonal Treatment as Background Therapy in Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer - Mayo Clinic

    ... Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer ... The objective of this study is to assess efficacy and safety of radium-223 ...

  4. Study of Radium-223 Dichloride Versus Placebo and Treatment With Exemestane / Everolimus in Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer - Mayo Clinic

    ... Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer ... The objective of this study is to assess efficacy and safety of radium 223 ...

  5. Osteoporosis - Doctors and departments - Mayo Clinic

    Ejigayehu G. Abate, M.D. · Osteoporosis, Metabolic bone disease, Hyperparathyroidism, Hypoparathyroidism ; Melissa H. Bogin, M.D. · Dementia, Arthritis, ...

  6. Mayo Rheumatologist Dr. Timothy Niewold Recognized for Achievements in Lupus Research

    She also was the director of rheumatology at Good Samaritan Hospital in Baltimore. Dr. Stevens developed the Hopkins-Good Samaritan Rheumatic Disease Unit, ...

  7. Research Projects - Tumor Angiogenesis and Vascular Biology Laboratory - Mayo Clinic Research

    We're investigating how the neurotransmitter dopamine affects the ability of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) to act ...

  8. Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Mayo Clinic

    About this study. The purpose of the rFVIIa for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) trial is to establish the first treatment ...

  9. Science Saturday: The newest building block for understanding rare disease - Mayo Clinic News Network

    In a study published April 8 in Arthritis & Rheumatology, a team of Mayo Clinic researchers led by rheumatologist Ali Duarte-Garcia, M.D., described the ...

  10. Maggie M. Paul, Ph.D. - Mayo Clinic Faculty Profiles

    Identifying health care delivery models for artificial intelligence (AI)-based interventions. · Clinically meaningful use of social risk factor data. · Telehealth ...